Cross-regulation between transcription and pre-mRNA splicing
转录和前 mRNA 剪接之间的交叉调节
基本信息
- 批准号:10735170
- 负责人:
- 金额:$ 50.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressArchitectureBase PairingBehaviorBindingBinding ProteinsBiochemicalBiologicalCellsChemicalsChemistryCodeCouplingDNAErythropoiesisEukaryotaEventExcisionGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGlobinGoalsGrantIndividualIntronsKnowledgeLabelLearningLengthLinkMammalian CellMammalsMass Spectrum AnalysisMeasuresMessenger RNAMethodsMitosisModelingMutateNuclearNuclear RNANucleotidesOculopharyngeal Muscular DystrophyOutputPhosphorylationPoint MutationPolymerasePositioning AttributePredispositionProteinsRNARNA FoldingRNA Polymerase IIRNA ProcessingRNA SplicingRNA StabilityRNA purificationRNA-Binding ProteinsRegulationRepressor ProteinsResearchResolutionRoleSaccharomycetalesSiteSplice-Site MutationSpliceosomesStructureSystemTailTestingTherapeuticTrans-ActivatorsTransactTranscriptTranscription ElongationTranscriptional RegulationU1 Small Nuclear RibonucleoproteinVaccinesYeastsbeta Globinexosomegene panelimprovedin vivomRNA Precursornoveloverexpressionposttranscriptionalrecruitresponsespecies differencetranscription factor
项目摘要
Abstract/Project Summary
The ubiquitous need for transcription and pre-mRNA processing in eukaryotes requires an understanding of
the mechanisms by which they occur simultaneously and regulate each other. Our long-term goals are to
determine the mechanisms that govern co-transcriptional intron removal and how co-transcriptional splicing
contributes to gene expression regulation. With previous support from this grant, my lab has pioneered
strategies for purifying and sequencing nascent RNA – the transient intermediates in transcription and RNA
processing – to quantify pre-mRNA splicing relative to the position of elongating RNA Polymerase II (Pol II) on
the gene. Most introns are removed as soon as they emerge from Pol II, indicating that Pol II and the spliceosome
are timed to act together and physically close to one another. Knowing this, our overall objectives are to (i)
elucidate the co-transcriptional mechanism of “all-or-none” RNA processing, in which individual nascent
transcripts are either fully spliced and cleaved at the 3’ end (all) or fully unspliced and uncleaved (none). My lab
discovered this recently by sequencing full-length nascent RNAs, and it is a major co-transcriptional regulatory
mechanism for b-globin gene expression. (ii) Determine how the potential for splicing becomes limited as
transcription proceeds and the nascent transcript gets longer. And (iii) Determine the fate and possible function
of the unprocessed transcripts. The central hypothesis is that the potential for nascent RNA to bind positive- and
negative-acting RNA binding proteins and/or to undergo intermolecular base-pairing and compaction increases
as the nascent chain grows during transcription. We will test this hypothesis by pursuing three specific aims: 1)
develop a method to determine the local base-pairing behavior of nascent RNA, using DMS chemistry and
nascent RNA purification. The results of this aim will tell us the degree to which nascent RNA becomes
transiently structured during transcription and if local structures correlate with positive or negative effects on
splicing, 2) identify activator and/or repressor proteins that accumulate on the growing nascent chain during
transcription, using biochemical purification and in vivo labeling approaches. 3) determine the nuclear response
to unprocessed “none” transcripts. Are they delayed in processing? Or will they be degraded? For this aim, we
have established the A-count method, which sequences the entire transcript from 5’ end to 3’ end, including the
whole length of the polyA tail, which will be counted by nucleotide type and number. Our preliminary results
show that the nuclear polyA binding protein PABPN1 is regulated by phosphorylation during mitosis,
suggesting differential fates for nuclear retained mRNAs with introns. PABPN1 is a protein mutated in
Oculopharyngeal muscular dystrophy (OPMD). The proposed research is significant because these mechanisms
operating at the level of pre-mRNA processing can change protein product amounts by at least 10-fold, showing
that RNA processing is as important for gene expression as regulation by transcription factors.
摘要/项目摘要
真核生物中普遍存在的转录和前信使核糖核酸加工的需要需要理解
它们同时发生并相互调节的机制。我们的长期目标是
确定控制共转录内含子去除的机制以及共转录剪接如何
有助于基因表达调控。在之前这笔赠款的支持下,我的实验室开创了
转录和RNA的瞬时中间产物新生RNA的纯化和测序策略
加工--相对于延长的RNA聚合酶II(POL II)的位置来量化前mRNA剪接
基因。大多数内含子一旦从Pol II出现就被移除,这表明Pol II和剪接体
都被安排在一起行动,而且身体上彼此接近。认识到这一点,我们的总体目标是:(一)
阐明“全有或全无”RNA加工的共转录机制,在该机制中,个体新生
转录本要么在3‘端完全剪接和切割(ALL),要么完全未剪接和未切割(NONE)。我的实验室
最近通过对全长的新生RNA进行测序发现了这一点,它是一种主要的共转录调控
B-珠蛋白基因表达的机制。(2)确定剪接潜力如何变得有限,因为
转录继续进行,新生的抄本变得更长。和(三)决定命运和可能的功能
未处理的成绩单。中心假设是,新生的RNA结合正性和
负性作用的RNA结合蛋白和/或经历分子间碱基配对和紧凑增加
随着新生的链在转录过程中增长。我们将通过追求三个具体目标来检验这一假设:1)
开发一种方法来确定新生RNA的局部碱基配对行为,使用DMS化学和
新生的RNA提纯。这个目标的结果将告诉我们,新生的RNA在多大程度上
转录过程中的瞬时结构以及局部结构是否与对
剪接,2)识别在生长的新生链上积累的激活蛋白和/或抑制蛋白
转录,使用生化纯化和体内标记方法。3)确定核反应
到未经处理的“无”成绩单。他们在处理过程中有没有延误?或者它们会被降级吗?为此,我们
已经建立了A-Count方法,该方法将整个转录本从5‘端到3’端进行测序,包括
Polya尾巴的全长,将按核苷酸类型和数量计算。我们的初步结果
证明核聚合体结合蛋白PABPN1在有丝分裂过程中受到磷酸化的调节,
提示核内含子保留的mRNAs的不同命运。PABPN1是一种突变的蛋白质
眼咽肌营养不良症(OPMD)。拟议的研究具有重要意义,因为这些机制
在前信使核糖核酸加工的水平上操作可以使蛋白质产品的数量至少增加10倍,这表明
RNA加工对基因表达的影响与转录因子的调控同等重要。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Long-read sequencing of nascent RNA reveals coupling among RNA processing events.
- DOI:10.1101/gr.232025.117
- 发表时间:2018-07
- 期刊:
- 影响因子:7
- 作者:Herzel L;Straube K;Neugebauer KM
- 通讯作者:Neugebauer KM
Nascent RNA and the Coordination of Splicing with Transcription.
新生 RNA 以及剪接与转录的协调。
- DOI:10.1101/cshperspect.a032227
- 发表时间:2019
- 期刊:
- 影响因子:7.2
- 作者:Neugebauer,KarlaM
- 通讯作者:Neugebauer,KarlaM
Splicing of Nascent RNA Coincides with Intron Exit from RNA Polymerase II.
- DOI:10.1016/j.cell.2016.02.045
- 发表时间:2016-04-07
- 期刊:
- 影响因子:64.5
- 作者:Oesterreich FC;Herzel L;Straube K;Hujer K;Howard J;Neugebauer KM
- 通讯作者:Neugebauer KM
Transcriptome-wide mapping reveals a diverse dihydrouridine landscape including mRNA.
整个转录组的映射揭示了包括mRNA在内的二氢岛景观。
- DOI:10.1371/journal.pbio.3001622
- 发表时间:2022-05
- 期刊:
- 影响因子:9.8
- 作者:Draycott, Austin S.;Schaening-Burgos, Cassandra;Rojas-Duran, Maria F.;Wilson, Loren;Scharfen, Leonard;Neugebauer, Karla M.;Nachtergaele, Sigrid;Gilbert, Wendy, V
- 通讯作者:Gilbert, Wendy, V
Nuclear mechanisms of gene expression control: pre-mRNA splicing as a life or death decision.
- DOI:10.1016/j.gde.2020.11.002
- 发表时间:2021-04
- 期刊:
- 影响因子:4
- 作者:Gordon JM;Phizicky DV;Neugebauer KM
- 通讯作者:Neugebauer KM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karla M Neugebauer其他文献
U2AF1 Splicing Factor Mutations Affect RNA Subcellular Compartmentalization in Myeloid Malignancies
- DOI:
10.1182/blood-2022-170043 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Giulia Biancon;Emma Busarello;Mark D Lessard;Edward Courvan;Dahyana Arias Escayola;Jennifer VanOudenhove;Veronica Lee;Mathew Krick;Joerg Bewersdorf;Karla M Neugebauer;Toma Tebaldi;Stephanie Halene - 通讯作者:
Stephanie Halene
mRNA: a complex(ed) life
信使核糖核酸:复杂的生命
- DOI:
10.1186/gb-2010-11-5-304 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:9.400
- 作者:
Michaela Müller;Karla M Neugebauer;Christian Eckmann - 通讯作者:
Christian Eckmann
Karla M Neugebauer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karla M Neugebauer', 18)}}的其他基金
DMA-Tudor interaction modules: a novel approach to Survival Motor Neuron protein (SMN) and Cajal body function
DMA-Tudor 相互作用模块:运动神经元生存蛋白 (SMN) 和 Cajal 身体功能的新方法
- 批准号:
10662555 - 财政年份:2022
- 资助金额:
$ 50.41万 - 项目类别:
DMA-Tudor interaction modules: a novel approach to Survival Motor Neuron protein (SMN) and Cajal body function
DMA-Tudor 相互作用模块:运动神经元生存蛋白 (SMN) 和 Cajal 身体功能的新方法
- 批准号:
10502150 - 财政年份:2022
- 资助金额:
$ 50.41万 - 项目类别:
Biogenesis and function of a novel class of stress-induced long non-coding RNAs
一类新型应激诱导的长非编码RNA的生物发生和功能
- 批准号:
10158039 - 财政年份:2021
- 资助金额:
$ 50.41万 - 项目类别:
Biogenesis and function of a novel class of stress-induced long non-coding RNAs
一类新型应激诱导的长非编码RNA的生物发生和功能
- 批准号:
10330607 - 财政年份:2021
- 资助金额:
$ 50.41万 - 项目类别:
Biogenesis and function of a novel class of stress-induced long non-coding RNAs
一类新型应激诱导的长非编码RNA的生物发生和功能
- 批准号:
10546449 - 财政年份:2021
- 资助金额:
$ 50.41万 - 项目类别:
Analysis of transcription and splicing coordination during erythropoeisis using single molecule RNA-seq
使用单分子 RNA-seq 分析红细胞生成过程中的转录和剪接协调
- 批准号:
10210330 - 财政年份:2020
- 资助金额:
$ 50.41万 - 项目类别:
Cross-regulation between transcription and pre-mRNA splicing
转录和前 mRNA 剪接之间的交叉调节
- 批准号:
9765599 - 财政年份:2015
- 资助金额:
$ 50.41万 - 项目类别:
Cross-regulation between transcription and pre-mRNA splicing
转录和前 mRNA 剪接之间的交叉调节
- 批准号:
9133424 - 财政年份:2015
- 资助金额:
$ 50.41万 - 项目类别:
Cross-regulation between transcription and pre-mRNA splicing
转录和前 mRNA 剪接之间的交叉调节
- 批准号:
10170363 - 财政年份:2015
- 资助金额:
$ 50.41万 - 项目类别:
Cross-regulation between transcription and pre-mRNA splicing
转录和前 mRNA 剪接之间的交叉调节
- 批准号:
10406927 - 财政年份:2015
- 资助金额:
$ 50.41万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 50.41万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 50.41万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 50.41万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 50.41万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 50.41万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 50.41万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 50.41万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 50.41万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 50.41万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 50.41万 - 项目类别:
Research Grant














{{item.name}}会员




